Oncoloxía médica
Servizo
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Universitat Autònoma de Barcelona (49)
2024
-
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU
Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 401-432
-
Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology
Clinical and Translational Oncology, Vol. 26, Núm. 1, pp. 98-108
-
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study
European urology oncology, Vol. 7, Núm. 3, pp. 447-455
2023
-
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
Biomedicine and Pharmacotherapy, Vol. 159
-
Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2679-2691), 10.1007/s12094-023-03216-3)
Clinical and Translational Oncology
-
Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section
Clinical and Translational Oncology, Vol. 25, Núm. 3, pp. 796-802
-
Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis
Clinical and Translational Oncology, Vol. 25, Núm. 4, pp. 941-958
-
Noninvasive detection of microsatellite instability in patients with endometrial cancer
International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217
-
SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)
Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2679-2691
2022
-
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer
Clinical Cancer Research, Vol. 28, Núm. 1, pp. 106-115
-
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial
British Journal of Cancer, Vol. 126, Núm. 6, pp. 874-880
-
Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression
Oncogene, Vol. 41, Núm. 13, pp. 1835-1850
-
Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
Clinical and Translational Oncology, Vol. 24, Núm. 6, pp. 1209-1214
2021
-
M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients
Gynecologic Oncology, Vol. 161, Núm. 3, pp. 681-686
-
Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas
Biomedicine and Pharmacotherapy, Vol. 140
-
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group
BMC Cancer, Vol. 21, Núm. 1
2020
-
Genomic profiling of uterine aspirates and cfDNA as an integrative liquid biopsy strategy in endometrial cancer
Journal of Clinical Medicine, Vol. 9, Núm. 2
-
Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blockade Agents
Frontiers in Oncology, Vol. 10
-
Interaction between the functional SNP rs2070951 in NR3C2 gene and high levels of plasma corticotropin-releasing hormone associates to postpartum depression
Archives of Women's Mental Health, Vol. 23, Núm. 3, pp. 413-420
-
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 38, Núm. 3, pp. 203-213